Programmable editing of primary MicroRNA switches stem cell differentiation and improves tissue regeneration
- PMID: 39333549
- PMCID: PMC11436717
- DOI: 10.1038/s41467-024-52707-6
Programmable editing of primary MicroRNA switches stem cell differentiation and improves tissue regeneration
Abstract
Programmable RNA editing is harnessed for modifying mRNA. Besides mRNA, miRNA also regulates numerous biological activities, but current RNA editors have yet to be exploited for miRNA manipulation. To engineer primary miRNA (pri-miRNA), the miRNA precursor, we present a customizable editor REPRESS (RNA Editing of Pri-miRNA for Efficient Suppression of miRNA) and characterize critical parameters. The optimized REPRESS is distinct from other mRNA editing tools in design rationale, hence enabling editing of pri-miRNAs that are not editable by other RNA editing systems. We edit various pri-miRNAs in different cells including adipose-derived stem cells (ASCs), hence attenuating mature miRNA levels without disturbing host gene expression. We further develop an improved REPRESS (iREPRESS) that enhances and prolongs pri-miR-21 editing for at least 10 days, with minimal perturbation of transcriptome and miRNAome. iREPRESS reprograms ASCs differentiation, promotes in vitro cartilage formation and augments calvarial bone regeneration in rats, thus implicating its potentials for engineering miRNA and applications such as stem cell reprogramming and tissue regeneration.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet.9, 102–114 (2008). - PubMed
-
- Jin, W., Wang, J., Liu, C.-P., Wang, H.-W. & Xu, R.-M. Structural basis for pri-miRNA recognition by Drosha. Mol. Cell78, 423–433.e425 (2020). - PubMed
-
- Rice, G. M., Shivashankar, V., Ma, E. J., Baryza, J. L. & Nutiu, R. Functional atlas of primary miRNA maturation by the microprocessor. Mol. Cell80, 892–902.e894 (2020). - PubMed
-
- Rupaimoole, R. & Slack, F. J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov.16, 203–222 (2017). - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
